SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
JINAN, China, Dec. 17, 2025 /PRNewswire/ -- A well-known international group conducted rigorous worldwide evaluations on both domestic and international suppliers in the same...
BEIJING, Dec. 17, 2025 /PRNewswire/ -- Realsee announced the official opening of Realsee3D, a dataset of 10,000 indoor 3D scenes, for academic research and...